KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsShares Issued
Ratios

Recursion Pharmaceuticals (RXRX) Long-Term Debt Issuances (2020)

Historic Long-Term Debt Issuances for Recursion Pharmaceuticals (RXRX) over the last 1 years, with Q2 2020 value amounting to $400000.0.

  • Recursion Pharmaceuticals' Long-Term Debt Issuances changed N/A to $400000.0 in Q2 2020 from the same period last year, while for Mar 2021 it was $400000.0, marking a year-over-year change of. This contributed to the annual value of $6.4 million for FY2020, which is 4616.42% down from last year.
  • Recursion Pharmaceuticals' Long-Term Debt Issuances amounted to $400000.0 in Q2 2020.
  • In the past 5 years, Recursion Pharmaceuticals' Long-Term Debt Issuances registered a high of $6.0 million during Q1 2020, and its lowest value of $400000.0 during Q2 2020.